Discovering, developing and delivering
For almost 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, like our insulin pens.
Our treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases.
From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world.
Safiatou Diallo lives in Guinea, has type 1 diabetes and is enrolled in the "Changing Diabetes® in Children" programme